Delivery Order SPE2DB22D3501-SPE2DB24FTP51

Award Date 11/20/23
Potential Completion Date 11/21/23
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,225.88, is a Firm Fixed Price Delivery Order for the procurement of "FIRST-MOUTHWASH BLM SUSPENSION 119ML" medical supplies. The contract has an ultimate completion date of September 20, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA). The prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order contract valued at $4,301.08 for the supply of "FIRST-MOUTHWASH BLM SUSPENSION 119ML" medical products. The contract has a May 11, 2023 completion date and is a firm fixed-price, delivery order type contract. No set-aside designation was used...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,109.98 Firm Fixed Price Delivery Order contract is for the provision of "FIRST-MOUTHWASH BLM SUSPENSION 237ML" medical products, with a period of performance through May 31, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award is for $2,224.40 and was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and covers the provision of "FIRST-MOUTHWASH BLM SUSPENSION 119ML" medical products. The contract has an ultimate completion date of December 26, 2023 and was awarded on December 22, 2023. No set-aside designation...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,040.92, is for the delivery of 4563152255 FIRST-MOUTHWASH BLM SUSPENSION 237ML products. The contract is a Firm Fixed Price Delivery Order with a completion date of December 21, 2023. This contract award is not associated with a set-aside designation. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $2,232.87, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the provision of "FIRST-MOUTHWASH BLM SUSPENSION 119ML", a medical product, with a performance period running through May 2, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,935.80, is a delivery order for the supply of "FIRST-MOUTHWASH BLM SUSPENSION 237ML". The award has no set-aside designation and is a firm fixed-price contract. The period of performance extends until September 19, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,915.06, is for the delivery of a medical product described as "FIRST-MOUTHWASH BLM SUSPENSION 237ML". The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of January 17, 2024. The award was made on January 16,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,506.14 firm fixed-price delivery order is for the supply of a FIRST-MOUTHWASH BLM SUSPENSION 119ML product, with a period of performance through March 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award, SPE2DB22D1106|SPE2DB24FEYW1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,728.76 and is for the delivery of "FIRST-MOUTHWASH BLM SUSPENSION 119ML", a medical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FTP51
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,750.67, is a Firm Fixed Price Delivery Order for the supply of "4562869393 ! FIRST-MOUTHWASH BLM SUSPENSION 119ML" to support military healthcare programs.

The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and there is no information provided about major subcontractors. The DLA, as a defense agency, is responsible for the logistical support of the U.S. military forces worldwide, including the supply of medical products and equipment.

Generated 5/12/25, 10:11 AM